Loading...

Dan Kelly, MD

Title(s)RSCH DATA ANL 2, Prevention & Public Health
SchoolChancellor/EVC/FAS
Phone415-476-6224
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Gorgas Memorial Institute DTMH2017Tropical Medicine
    University of California, San FranciscoInfectious Diseases2016Medicine
    University of California, BerkeleyMPH2016Public Health - Epidemiology
    Baylor College of MedicineInternal Medicine2011Medicine
    Albert Einstein College of MedicineMD2008Medicine
    Princeton UniversityAB2003Chemistry
    Collapse Awards and Honors
    National Institutes of Health2016Loan Repayment Program Award
    University of California, Berkeley2016Sidney MacDonald Russell Family Graduate Fellowship Award
    University of California2015Presidents Global Food Initiative Fellowship Award
    The Clinton Foundation2015Clinton Global Citizen Award (recipient: Wellbody Alliance)
    Malvern Preparatory School2015St. Augustine Alumni Award
    Ministry of Health in Sierra Leone2011Fulbright Scholarship
    Yeshiva University2008Point of Light
    Global Health Education Consortium2008Velji Global Health Project of the Year Award
    Albert Einstein College of Medicine2008Albert S. Kuperman Award for Field Work in Global Health

    Collapse Overview 
    Collapse Overview
    After graduating from Princeton University, Dan Kelly, MD, MPH, went to Albert Einstein College of Medicine, where he pursued a Global Health Fellowship after his third year. In Sierra Leone, a local doctor and he were inspired to start Wellbody Alliance, a health and human rights non-profit organization that provides high-quality healthcare to the rural poor. After internal medicine residency and with a Fulbright scholarship, Dan conducted HIV research in Sierra Leone while building the community health work of Wellbody Alliance to care for the half million people living in rural Kono district. Dan was an infectious disease fellow at University of California, San Francisco, and an MPH student at University of California, Berkeley, when Ebola struck Sierra Leone. After a close friend died of Ebola in August 2014, Dan decided to take a leave of absence from fellowship training and the MPH to take a full-time leadership role in the Ebola response. Dan reached out to his long-time mentor Paul Farmer and established a coalition with Partners In Health in Sierra Leone. Dan spent eight months on the ground in Sierra Leone during the Ebola epidemic and led multiple frontiers of work, ranging from Ebola care to clinical trials of innovative Ebola diagnostics, and integrated Wellbody Alliance into Partners In Health. Dan returned to UCSF and UCB and finished his infectious disease fellowship and MPH. Dan continues to conduct Ebola research in Sierra Leone and Liberia. He employs sero-epidemiology, transmission mapping and modeling techniques, and clinical research cohorts to investigate asymptomatic Ebola virus infection and mild illness. Dan has published on Ebola in New England Journal of Medicine, Nature, and The Lancet.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kelly JD, Worden L, Wannier SR, Hoff NA, Mukadi P, Sinai C, Ackley S, Chen X, Gao D, Selo B, Mossoko M, Okitolonda-Wemakoy E, Richardson ET, Rutherford GW, Lietman TM, Muyembe-Tamfum JJ, Rimoin AW, Porco TC. Projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo, as of May 27, 2018. PLoS One. 2019; 14(3):e0213190. PMID: 30845236.
      View in: PubMed
    2. Kelly JD, Weiser SD, Wilson B, Cooper JB, Glayweon M, Sneller MC, Drew C, Steward WT, Reilly C, Johnson K, Fallah MP. Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study. PLoS Negl Trop Dis. 2019 Feb 27; 13(2):e0007185. PMID: 30811388.
      View in: PubMed
    3. Sié A, Coulibaly B, Adama S, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Kelly JD, Doan T, Lietman TM, Keenan JD, Oldenburg CE. Antibiotic Prescription Patterns among Children Younger than 5 Years in Nouna District, Burkina Faso. Am J Trop Med Hyg. 2019 Jan 28. PMID: 30693860.
      View in: PubMed
    4. Kelly JD, Frankfurter R, Lurton G, Conteh S, Empson SF, Daboh F, Kargbo B, Giordano T, Mukherjee J, Barrie MB. Evaluation of a community-based ART programme after tapering home visits in rural Sierra Leone: a 24-month retrospective study. SAHARA J. 2018 12; 15(1):138-145. PMID: 30257611.
      View in: PubMed
    5. Kelly JD, Hickey MD, Schlough GW, Conteh S, Sesay M, Rutherford GW, Giordano TP, Weiser SD. Understanding why HIV-infected persons disengaged from pre-ART care in Freetown, Sierra Leone: a qualitative study. AIDS Care. 2018 Aug 26; 1-4. PMID: 30146898.
      View in: PubMed
    6. Kelly JD, Hoff NA, Spencer D, Musene K, Bramble MS, McIlwain D, Okitundu D, Porco TC, Rutherford GW, Glymour MM, Bjornson Z, Mukadi P, Okitolonda-Wemakoy E, Nolan GP, Muyembe-Tamfum JJ, Rimoin AW. Neurological, cognitive, and psychological findings among survivors of Ebola virus disease from the 1995 Ebola outbreak in Kikwit, Democratic Republic of Congo: a cross-sectional study. Clin Infect Dis. 2018 Aug 10. PMID: 30107392.
      View in: PubMed
    7. Dhillon RS, Srikrishna D, Kelly JD. Deploying RDTs in the DRC Ebola outbreak. Lancet. 2018 06 23; 391(10139):2499-2500. PMID: 29887274.
      View in: PubMed
    8. Kelly JD, Mukadi P, Dhillon RS. Beyond vaccines: improving survival rates in the DRC Ebola outbreak. Lancet. 2018 06 09; 391(10137):2321. PMID: 29807665.
      View in: PubMed
    9. Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Drasher M, Schlough GW, Dierberg K, Koedoyoma S, Lindan CP, Jones JH, Chamie G, Worden L, Greenhouse B, Weiser SD, Porco TC, Rutherford GW, Richardson ET. Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16. J Infect Dis. 2018 Mar 28; 217(8):1214-1221. PMID: 29325149.
      View in: PubMed
    10. Kelly JD, Richardson ET, Drasher M, Barrie MB, Karku S, Kamara M, Hann K, Dierberg K, Hubbard A, Lindan CP, Farmer PE, Rutherford GW, Weiser SD. Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional Study. Am J Trop Med Hyg. 2018 May; 98(5):1484-1488. PMID: 29557329.
      View in: PubMed
    11. Richardson ET, Kelly JD, Sesay O, Drasher MD, Desai IK, Frankfurter R, Farmer PE, Barrie MB. The symbolic violence of 'outbreak': A mixed methods, quasi-experimental impact evaluation of social protection on Ebola survivor wellbeing. Soc Sci Med. 2017 12; 195:77-82. PMID: 29156248.
      View in: PubMed
    12. Kelly JD, Reid MJ, Lahiff M, Tsai AC, Weiser SD. Community-Level HIV Stigma as a Driver for HIV Transmission Risk Behaviors and Sexually Transmitted Diseases in Sierra Leone: A Population-Based Study. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):399-407. PMID: 28406807.
      View in: PubMed
    13. Richardson ET, Fallah MP, Kelly JD, Barrie MB. The predicament of patients with suspected Ebola - Authors' reply. Lancet Glob Health. 2017 07; 5(7):e660-e661. PMID: 28619225.
      View in: PubMed
    14. Richardson ET, Barrie MB, Nutt CT, Kelly JD, Frankfurter R, Fallah MP, Farmer PE. The Ebola suspect's dilemma. Lancet Glob Health. 2017 03; 5(3):e254-e256. PMID: 28193386.
      View in: PubMed
    15. Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE. Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey. PLoS Negl Trop Dis. 2016 11; 10(11):e0005087. PMID: 27846221.
      View in: PubMed
    16. Cancedda C, Davis SM, Dierberg KL, Lascher J, Kelly JD, Barrie MB, Koroma AP, George P, Kamara AA, Marsh R, Sumbuya MS, Nutt CT, Scott KW, Thomas E, Bollbach K, Sesay A, Barrie A, Barrera E, Barron K, Welch J, Bhadelia N, Frankfurter RG, Dahl OM, Das S, Rollins RE, Eustis B, Schwartz A, Pertile P, Pavlopoulos I, Mayfield A, Marsh RH, Dibba Y, Kloepper D, Hall A, Huster K, Grady M, Spray K, Walton DA, Daboh F, Nally C, James S, Warren GS, Chang J, Drasher M, Lamin G, Bangura S, Miller AC, Michaelis AP, McBain R, Broadhurst MJ, Murray M, Richardson ET, Philip T, Gottlieb GL, Mukherjee JS, Farmer PE. Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis. 2016 10 15; 214(suppl 3):S153-S163. PMID: 27688219.
      View in: PubMed
    17. Dhillon RS, Kelly JD, Srikrishna D, Garry RF. Overlooking the importance of immunoassays. Lancet Infect Dis. 2016 10; 16(10):1109-1110. PMID: 27676344.
      View in: PubMed
    18. Richardson ET, Barrie MB, Kelly JD, Dibba Y, Koedoyoma S, Farmer PE. Biosocial Approaches to the 2013-2016 Ebola Pandemic. Health Hum Rights. 2016 06; 18(1):115-128. PMID: 27781004.
      View in: PubMed
    19. Kelly JD, Cohen J, Grimes B, Philip SS, Weiser SD, Riley ED. High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies. J Womens Health (Larchmt). 2016 08; 25(8):840-5. PMID: 27243474.
      View in: PubMed
    20. Semper AE, Broadhurst MJ, Richards J, Foster GM, Simpson AJ, Logue CH, Kelly JD, Miller A, Brooks TJ, Murray M, Pollock NR. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study. PLoS Med. 2016 Mar; 13(3):e1001980. PMID: 27023868.
      View in: PubMed
    21. Kelly JD, Schlough GW, Conteh S, Barrie MB, Kargbo B, Giordano TP. The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis. PLoS One. 2016; 11(2):e0149584. PMID: 26901765; PMCID: PMC4763157.
    22. Kelly JD, Weiser SD, Tsai AC. Proximate Context of HIV Stigma and Its Association with HIV Testing in Sierra Leone: A Population-Based Study. AIDS Behav. 2016 Jan; 20(1):65-70. PMID: 25771909; PMCID: PMC4570874.
    23. Kelly JD, Richardson ET, Barry M. Persistent Ebola Virus in the Eye. N Engl J Med. 2015 11 12; 373(20):1981-2. PMID: 26559588.
      View in: PubMed
    24. Dhillon RS, Kelly JD. Community Trust and the Ebola Endgame. N Engl J Med. 2015 Aug 27; 373(9):787-9. PMID: 26222382.
      View in: PubMed
    25. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, Sankoh AB, Kanu S, Jalloh A, Ton Q, Sarchet N, George P, Perkins MD, Wonderly B, Murray M, Pollock NR. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015 Aug 29; 386(9996):867-74. PMID: 26119838.
      View in: PubMed
    26. Kelly JD, Grace Lin SY, Barry PM, Keh C, Higashi J, Metcalfe JZ. Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection. Am J Respir Crit Care Med. 2014 Dec 01; 190(11):1316-8. PMID: 25436783.
      View in: PubMed
    27. Kelly JD. Make diagnostic centres a priority for Ebola crisis. Nature. 2014 Sep 11; 513(7517):145. PMID: 25209763.
      View in: PubMed
    28. Rotte M, Fields JM, Torres S, Dominick C, Kelly JD. Use of ultrasound to diagnose and manage a five-liter empyema in a rural clinic in sierra leone. Case Rep Emerg Med. 2014; 2014:173810. PMID: 25050185; PMCID: PMC4090470.
    29. Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care. 2014 Sep-Oct; 25(5):405-13. PMID: 24508174; PMCID: PMC4125558.
    30. Kelly JD, Hubenthal EA, Lurton G, Empson SF, Barrie MB, Kargbo B, Wagner GJ, Giordano TP. Multiple self-report measures of antiretroviral adherence correlated in Sierra Leone, but did they agree? Int J STD AIDS. 2013 Dec; 24(12):931-7. PMID: 23970613.
      View in: PubMed
    31. Kelly JD, Barrie MB, Ross RA, Temple BA, Moses LM, Bausch DG. Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone. BMC Int Health Hum Rights. 2013 Jan 02; 13:2. PMID: 23282054; PMCID: PMC3562201.
    32. Kelly JD, LeLeux TM, Citron DR, Musher DM, Giordano TP. Ulceronodular syphilis (lues maligna praecox) in a person newly diagnosed with HIV infection. BMJ Case Rep. 2011 Jul 20; 2011. PMID: 22689612; PMCID: PMC4545021.
    33. Kelly JD, Teeter LD, Graviss EA, Tweardy DJ. Intracranial tuberculomas in adults: a report of twelve consecutive patients in Houston, Texas. Scand J Infect Dis. 2011 Oct; 43(10):785-91. PMID: 21696248.
      View in: PubMed
    34. Kelly JD, Giordano TP. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011 May 15; 25(8):1137; reply 1138-9. PMID: 21537118.
      View in: PubMed
    35. Kelly JD, Barrie MB. Global health: will positive changes for Sierra Leone's health professionals mean the end of its Brain Drain? J Public Health Policy. 2010 Apr; 31(1):112-4. PMID: 20200532.
      View in: PubMed
    36. Kelly JD. Haitian amputees--lessons learned from Sierra Leone. N Engl J Med. 2010 Mar 18; 362(11):e42. PMID: 20200359.
      View in: PubMed